Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 262

1.

The role of follicular T helper cells in the humoral alloimmune response after clinical organ transplantation.

van Besouw NM, Mendoza Rojas A, Baan CC.

HLA. 2019 Aug 19. doi: 10.1111/tan.13671. [Epub ahead of print] Review.

PMID:
31423738
2.

The effects of an IL-21 receptor antagonist on the alloimmune response in a humanized mouse skin transplant model.

de Leur K, Luk F, van den Bosch TPP, Dieterich M, van der Laan LJW, Hendriks RW, Clahsen-van Groningen MC, Issa F, Baan CC, Hoogduijn MJ.

Transplantation. 2019 May 7. doi: 10.1097/TP.0000000000002773. [Epub ahead of print]

PMID:
31343579
3.

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.

Hurkmans DP, Verhoeven JGHP, de Leur K, Boer K, Joosse A, Baan CC, von der Thüsen JH, van Schaik RHN, Mathijssen RHJ, van der Veldt AAM, Hesselink DA.

J Immunother Cancer. 2019 Jul 12;7(1):182. doi: 10.1186/s40425-019-0653-6.

4.

Mesenchymal Stromal Cells Are Retained in the Renal Cortex Independently of Their Metabolic State After Renal Intra-Arterial Infusion.

Sierra-Parraga JM, Munk A, Andersen C, Lohmann S, Moers C, Baan CC, Ploeg RJ, Pool M, Keller AK, Møller BK, Leuvenink H, Hoogduijn MJ, Jespersen B, Eijken M.

Stem Cells Dev. 2019 Aug 1. doi: 10.1089/scd.2019.0105. [Epub ahead of print]

PMID:
31280676
5.

Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.

Peters FS, Peeters AMA, van den Bosch TPP, Mooyaart AL, van de Wetering J, Betjes MGH, Baan CC, Boer K.

Clin Exp Immunol. 2019 Sep;197(3):341-351. doi: 10.1111/cei.13309. Epub 2019 May 30.

6.

Nanoparticle Release by Extended Criteria Donor Kidneys During Normothermic Machine Perfusion.

Woud WW, Merino A, Hoogduijn MJ, Boer K, van den Hoogen MWF, Baan CC, Minnee RC.

Transplantation. 2019 May;103(5):e110-e111. doi: 10.1097/TP.0000000000002642. No abstract available.

PMID:
31033854
7.

Effects of Normothermic Machine Perfusion Conditions on Mesenchymal Stromal Cells.

Sierra Parraga JM, Rozenberg K, Eijken M, Leuvenink HG, Hunter J, Merino A, Moers C, Møller BK, Ploeg RJ, Baan CC, Jespersen B, Hoogduijn MJ.

Front Immunol. 2019 Apr 10;10:765. doi: 10.3389/fimmu.2019.00765. eCollection 2019.

8.

The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection.

van Besouw NM, Yan L, de Kuiper R, Klepper M, Reijerkerk D, Dieterich M, Roelen DL, Claas FHJ, Clahsen-van Groningen MC, Hesselink DA, Baan CC.

Front Immunol. 2019 Apr 9;10:748. doi: 10.3389/fimmu.2019.00748. eCollection 2019.

9.

Characterization of donor and recipient CD8+ tissue-resident memory T cells in transplant nephrectomies.

de Leur K, Dieterich M, Hesselink DA, Corneth OBJ, Dor FJMF, de Graav GN, Peeters AMA, Mulder A, Kimenai HJAN, Claas FHJ, Clahsen-van Groningen MC, van der Laan LJW, Hendriks RW, Baan CC.

Sci Rep. 2019 Apr 12;9(1):5984. doi: 10.1038/s41598-019-42401-9.

10.

Targeted Proteomic Analysis Detects Acute T Cell-Mediated Kidney Allograft Rejection in Belatacept-Treated Patients.

van der Zwan M, Hesselink DA, Clahsen-van Groningen MC, Baan CC.

Ther Drug Monit. 2019 Apr;41(2):243-248. doi: 10.1097/FTD.0000000000000587.

PMID:
30883517
11.

Repairing and Regenerating Organs for Transplantation Has Become a Reality.

Baan CC.

Transplantation. 2019 Feb;103(2):224-226. doi: 10.1097/TP.0000000000002557. No abstract available.

PMID:
30681647
12.

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients.

van der Zwan M, Baan CC, Colvin RB, Smith RN, White RA, Ndishabandi D, Nigg AL, van den Bosch TPP, de Graav GN, Clahsen-van Groningen MC, Hesselink DA.

Transplant Direct. 2018 Dec 20;5(1):e418. doi: 10.1097/TXD.0000000000000857. eCollection 2019 Jan.

13.

Short communication: Targeted proteomic analysis detects acute T cell-mediated kidney allograft rejection in belatacept-treated patients.

van der Zwan M, Hesselink DA, Clahsen-van Groningen MC, Baan CC.

Ther Drug Monit. 2018 Dec 4. doi: 10.1097/FTD.0000000000000587. [Epub ahead of print]

PMID:
30521499
14.

Current State of Renal Regenerative Therapies.

Shankar AS, Hoorn EJ, Gribnau J, Baan CC, Hoogduijn MJ.

Transplantation. 2019 Feb;103(2):250-261. doi: 10.1097/TP.0000000000002547. Review.

PMID:
30489479
15.

The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy.

van der Zwan M, Clahsen-Van Groningen MC, Roodnat JI, Bouvy AP, Slachmuylders CL, Weimar W, Baan CC, Hesselink DA, Kho MML.

Ann Transplant. 2018 Aug 17;23:577-590. doi: 10.12659/AOT.909646.

16.

Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients.

Kannegieter NM, Hesselink DA, Dieterich M, de Graav GN, Kraaijeveld R, Baan CC.

PLoS One. 2018 Jul 23;13(7):e0201113. doi: 10.1371/journal.pone.0201113. eCollection 2018.

17.

Liquid Biopsies to Monitor Solid Organ Transplant Function: A Review of New Biomarkers.

Verhoeven JGHP, Boer K, Van Schaik RHN, Manintveld OC, Huibers MMH, Baan CC, Hesselink DA.

Ther Drug Monit. 2018 Oct;40(5):515-525. doi: 10.1097/FTD.0000000000000549. Review.

PMID:
29957668
18.

Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer.

Peters FS, Peeters AMA, Mandaviya PR, van Meurs JBJ, Hofland LJ, van de Wetering J, Betjes MGH, Baan CC, Boer K.

Clin Epigenetics. 2018 Jun 18;10:81. doi: 10.1186/s13148-018-0519-7. eCollection 2018.

19.

Epigenetic changes in umbilical cord mesenchymal stromal cells upon stimulation and culture expansion.

De Witte SFH, Peters FS, Merino A, Korevaar SS, Van Meurs JBJ, O'Flynn L, Elliman SJ, Newsome PN, Boer K, Baan CC, Hoogduijn MJ.

Cytotherapy. 2018 Jul;20(7):919-929. doi: 10.1016/j.jcyt.2018.05.005. Epub 2018 Jun 20.

PMID:
29934259
20.

Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms.

de Graav GN, van der Zwan M, Baan CC, Janssen JAMJL, Hesselink DA.

Transplant Direct. 2018 Feb 20;4(3):e350. doi: 10.1097/TXD.0000000000000767. eCollection 2018 Mar.

Supplemental Content

Loading ...
Support Center